ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
6,144.15
0.24%
US Tech 100
21,553.60
-0.10%
다우존스 지수
44,627.59
0.16%
Bitcoin
96,818.31
0.19%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ

  6. Shattuck Labs Inc (STTK) 시세

Shattuck Labs Inc

Shattuck Labs Inc (STTK)

NASDAQ
1.26
0.00
(0.00%)
마감 20 2월 6:00AM
15분 지연
1.308
0.048
(3.81%)
시간외 거래: 9:38AM
15분 지연

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

프리미엄

주요 통계 및 세부정보

가격
1.308
매수가
1.25
매도가
1.31
거래량
130,289
1.21 일간 변동폭 1.28
0.94 52주 범위 11.76
market_cap
62.444M
전일 종가
1.26
개장가
1.24
최근 거래 시간
5
@
1.3
마지막 거래 시간
재정 규모
US$ 163,565
VWAP
1.2554
평균 볼륨(3m)
199,737
발행 주식
47,739,708
배당수익률
-
주가수익률
-0.69
주당순이익(EPS)
-1.83
매출
1.66M
순이익
-87.3M

Shattuck Labs Inc 정보

Shattuck Labs Inc is a clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine. Its product candidate, SL-172154, has been rationally designed to simultaneously inhibit the CD47/SIRPa checkpoint interaction to restor... Shattuck Labs Inc is a clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine. Its product candidate, SL-172154, has been rationally designed to simultaneously inhibit the CD47/SIRPa checkpoint interaction to restore an anti-tumor immune response and to activate the CD40 costimulatory receptor to bolster an immune response. Its product candidate, SL-279252, which is being developed in collaboration with Takeda Pharmaceuticals, or Takeda, has been rationally designed to simultaneously inhibit the PD-1/PD-L1 interaction and activate the OX40 receptor. 더 보기

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
www.shattucklabs.com
본부
Dover, Delaware, USA
설립됨
-
Shattuck Labs Inc is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker STTK. The last closing price for Shattuck Labs was US$1.26. Over the last year, Shattuck Labs shares have traded in a share price range of US$ 0.94 to US$ 11.76.

Shattuck Labs currently has 47,739,708 shares in issue. The market capitalisation of Shattuck Labs is US$60.15 million. Shattuck Labs has a price to earnings ratio (PE ratio) of -0.69.

STTK 최신 뉴스

추가 뉴스

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
29 1월 2025
STTK (0.00%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
29 1월 2025
STTK (0.00%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
29 1월 2025
STTK (0.00%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
29 1월 2025
STTK (0.00%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
14 1월 2025
STTK (0.00%)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
10.12810.84745762711.181.361.15967371.2701631CS
40.15813.73913043481.151.361.11190531.21957631CS
120.24823.39622641511.061.391.021997371.20432999CS
26-2.062-61.18694362023.373.950.943892791.60701248CS
52-8.002-85.95059076269.3111.760.943888584.1650213CS
156-3.452-72.52100840344.7611.760.943262124.85679057CS
260-17.302-92.971520687818.6160.51620.942916049.09732894CS

STTK - Frequently Asked Questions (FAQ)

What is the current Shattuck Labs share price?
The current share price of Shattuck Labs is US$ 1.308
How many Shattuck Labs shares are in issue?
Shattuck Labs has 47,739,708 shares in issue
What is the market cap of Shattuck Labs?
The market capitalisation of Shattuck Labs is USD 60.15M
What is the 1 year trading range for Shattuck Labs share price?
Shattuck Labs has traded in the range of US$ 0.94 to US$ 11.76 during the past year
What is the PE ratio of Shattuck Labs?
The price to earnings ratio of Shattuck Labs is -0.69
What is the cash to sales ratio of Shattuck Labs?
The cash to sales ratio of Shattuck Labs is 36.31
What is the reporting currency for Shattuck Labs?
Shattuck Labs reports financial results in USD
What is the latest annual turnover for Shattuck Labs?
The latest annual turnover of Shattuck Labs is USD 1.66M
What is the latest annual profit for Shattuck Labs?
The latest annual profit of Shattuck Labs is USD -87.3M
What is the registered address of Shattuck Labs?
The registered address for Shattuck Labs is 108 LAKELAND AVE, DOVER, DELAWARE, 19901
What is the Shattuck Labs website address?
The website address for Shattuck Labs is www.shattucklabs.com
Which industry sector does Shattuck Labs operate in?
Shattuck Labs operates in the PHARMACEUTICAL PREPARATIONS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
JTAIJet AI Inc
US$ 10.1006
(148.78%)
149.38M
EDITEditas Medicine Inc
US$ 3.19
(83.33%)
49.89M
SINTSiNtx Technologies Inc
US$ 4.79
(69.86%)
70.97M
LYTLytus Technologies Holdings PTV Ltd
US$ 0.363
(63.07%)
215.48M
AGHAureus Greenway Holdings Inc
US$ 3.8501
(42.07%)
1.02M
CNSPCNS Pharmaceuticals Inc
US$ 0.0838
(-41.19%)
88.17M
HCTIHealthcare Triangle Inc
US$ 0.4409
(-38.76%)
3.19M
NKLANikola Corporation
US$ 0.4711
(-38.49%)
110.5M
BPTHBio Path Holdings Inc
US$ 0.1322
(-37.05%)
2.14M
GLSTUGlobal Star Acquisition Inc
US$ 7.26
(-36.04%)
4.41k
ADTXAditxt Inc
US$ 0.1288
(17.09%)
612.1M
BHATBlue Hat Interactive Entertainment Technology
US$ 0.0616
(13.03%)
482.51M
SMCISuper Micro Computer Inc
US$ 60.25
(7.97%)
338.03M
LYTLytus Technologies Holdings PTV Ltd
US$ 0.363
(63.07%)
215.48M
NVDANVIDIA Corporation
US$ 139.23
(-0.12%)
168.02M

STTK Discussion

게시물 보기
TrendTrade2016 TrendTrade2016 4 월 전
STTK COMING OFF BOTTOM
👍️0
glenn1919 glenn1919 4 월 전
STTK............................https://stockcharts.com/h-sc/ui?s=STTK&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 6 월 전
STTK under $4
👍️0
PonkenPlonken PonkenPlonken 9 월 전
absolutely revolutionary data in HR MDS... compare to SOC!!! HMAs show a ORR 30%, CR 10-20%
(also beats venetoclax + HMA in TP53m AML)

Observed 79% Objective Response Rate (ORR) in frontline HR-MDS patients, primarily with TP53 mutations; initial complete response (CR)/marrow complete response (mCR) rate of 64% –

– Observed 27% initial CR/complete response with incomplete hematologic recovery (CRi) in frontline TP53m AML patients, and 5/11 evaluable patients achieved stable disease with decreasing blast counts and peripheral blood count improvement, these patients continue on treatment
👍️0
Monksdream Monksdream 10 월 전
STTK new 52 week high
👍️0
Monksdream Monksdream 1 년 전
STTK new 52 week high
👍️0
Monksdream Monksdream 1 년 전
STTK new 52 week low
👍️0
tbonaces80 tbonaces80 1 년 전
Takeda gonna tender on next trial fast track
👍️0
tbonaces80 tbonaces80 1 년 전
load it-going to 10+
👍️0
subslover subslover 1 년 전
No fooling? So you say a 1.75% profit for a two-hour trade is a bad trade?
👍️0
tbonaces80 tbonaces80 1 년 전
Bad trade
👍️0
subslover subslover 1 년 전
Ok. I got out of this POS this morning at $5.00, got lucky is all
👍️0
TheFinalCD TheFinalCD 1 년 전
@ 4.29 I was just looking for a move under $4 and it did

small gain, but I didnt know how many borrows I could get if it went against me

sometimes I go short, and get upside down and cant average up, because broker all of a sudden has NO available shares to short= your stuck

so thats why I dont short much
👍️0
subslover subslover 1 년 전
What price did you short?tia
👍️0
TheFinalCD TheFinalCD 1 년 전
I shorted it... Its just Phase 1

AI bot hyper extended the POP

I used to chase these Pase 1 rallys, lost lots of money doing so

some of my biggest losses ever

Phase 1 Gap & Traps
👍️0
subslover subslover 1 년 전
Did you see this open? $7.28! then immediately dropped down to $2.50 omg. I'm in at $3.00 just hoping for the best. Worth a shot
👍️0
TheFinalCD TheFinalCD 1 년 전
https://twitter.com/TigerLineTrades/status/1734900423301988796
👍️0
subslover subslover 1 년 전
$TSOI's new Introducing the ALScell™, also known as the JadiCell™ – Now, these ALScells are not your run-of-the-mill mesenchymal stem cells; they're basically the overachievers of the cellular world. These ALScells have it all – enhanced growth factor production, like they've been hitting the gym and drinking protein shakes on a regular basis. They can secrete exosomes , outshining their stem cell peers who are still trying to figure out how to tie their cellular shoelaces.

But wait, there's more! These ALScells are not just content with being academically gifted; they've got some serious street smarts too. Superior angiogenic and neurogenic abilities mean they're like the cool kids who not only excel in science class but also throw legendary parties in the cellular neighborhood.

And guess what? Exosomes are not just a fancy word; they're the VIP pass to the cure of many cancers. It's like the ALScells are hosting the party, and exosomes are the invitations that cancer cells can't resist.

So, say hello to the ALScell™ – the cellular superhero ready to save the day, one enhanced growth factor at a time, and unlocking cures like a boss!
Bullish
BULLISH
👍️0
Awl416 Awl416 1 년 전
Shattuck Labs Announces Positive Initial Topline Data from Ongoing Phase 1 A/B Dose Expansion Clinical Trial of SL-172154 with Azacitidine in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) Pati
👍️0
Monksdream Monksdream 1 년 전
STTK under $2
👍️0

최근 히스토리

NASDAQ
STTK
Shattuck Labs
UNSW3
OVCETH
OVCODE
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지